Vassilakopoulos, T., Muñoz, J., Huang, H., Kawashima, I., Oh, S. Y., Jurczak, W., Burgues, J. M. B., Bai, O., Berkovits, A., Zhou, K., Hoffmann, M., Westin, J., Bouzani, M., Kwiatek, M., Huang, T., Gkasiamis, A., Patel, A., Boucaud, F., Petel, A., Perna, S., Nowakowski, G. (2025). Golseek-1: A Phase 3, double-blind, randomized study of golcadomide (GOLCA), a potential, first-in-class, oral CELMoD™ agent, + R-CHOP vs placebo + R-CHOP in patients with previously untreated, high-risk, large B-cell lymphoma. Blood. https://doi.org/10.1182/blood-2025-3704